EcoR1 Capital, LLC
Q2 2025 13F Holdings
- Locationsan francisco, CA
- Num holdings
37
- Value ($000)
$1,689,331
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001587114
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ZYME ZYMEWORKS INC | COM | 98985Y108 | $288.28 M | 17 % | 22,970,388 | ||
APLS APELLIS PHARMACEUTICALS INC | COM | 03753U106 | $205.92 M | 12 % | 11,895,808 | ||
JAZZ PHARMACEUTICALS PLC | SHS USD | G50871105 | $181.09 M | 11 % | 1,706,469 | ||
ANAB ANAPTYSBIO INC | COM | 032724106 | $174.94 M | 10 % | 7,880,094 | ||
CRNX CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | $123.33 M | 7 % | 4,288,120 | ||
ITOS ITEOS THERAPEUTICS INC | COM | 46565G104 | $106.57 M | 6 % | 10,688,978 | ||
CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | $67.57 M | 4 % | 1,389,276 | ||
UNIQURE NV | SHS | N90064101 | $55.61 M | 3 % | 3,988,971 | ||
TNGX TANGO THERAPEUTICS INC | COM | 87583X109 | $54.43 M | 3 % | 10,630,736 | ||
XNCR XENCOR INC | COM | 98401F105 | $48.30 M | 3 % | 6,144,767 |
Rows Per Page
10
- 10
- 50
- 100